PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Abivax SA (ABVX.PA)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINFR0012333284
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap€625.40M
EPS (TTM)-€3.43
Total Revenue (TTM)€2.25M
Gross Profit (TTM)€1.87M
EBITDA (TTM)-€92.08M
Year Range€7.89 - €15.42
Target Price€29.80

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of €10,000 in Abivax SA, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-30.00%-20.00%-10.00%0.00%10.00%MayJuneJulyAugustSeptemberOctober
-25.93%
6.70%
ABVX.PA (Abivax SA)
Benchmark (^GSPC)

Returns By Period

Abivax SA had a return of 1.22% year-to-date (YTD) and -32.75% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date1.22%19.68%
1 month-13.11%1.07%
6 months-25.93%9.66%
1 year-32.75%33.12%
5 years (annualized)4.84%14.47%
10 years (annualized)N/A11.27%

Monthly Returns

The table below presents the monthly returns of ABVX.PA, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202423.01%4.80%5.85%10.15%-14.77%-7.15%-5.65%3.81%-11.19%1.22%
202311.97%-4.77%5.46%117.27%20.26%-14.10%12.31%-0.11%-14.29%-40.93%3.39%7.21%58.90%
2022-17.69%-12.55%19.71%-22.68%-7.68%-40.43%-20.17%-4.43%-0.38%-9.43%-0.00%-14.17%-78.35%
2021-9.59%-4.82%-39.19%28.33%23.38%3.68%1.69%4.33%-5.90%-1.69%-16.38%17.73%-17.01%
2020-10.64%-30.52%21.71%8.33%11.05%1.46%-3.85%-8.90%5.60%-3.33%25.27%47.64%52.55%
2019-14.02%-11.79%-0.56%22.06%-17.06%-16.15%23.35%-10.27%-6.08%21.19%22.93%92.08%90.46%
20183.13%-9.78%-6.60%-0.13%-9.21%0.59%-2.19%0.30%4.47%-18.69%87.37%10.86%37.20%
2017-16.83%14.50%15.17%33.14%48.37%-4.62%-15.05%-2.53%9.55%-0.51%-15.91%-12.65%36.98%
201614.49%-14.88%-4.21%-20.67%-2.10%-55.26%-9.59%-3.61%81.00%0.55%-3.30%-10.51%-55.48%
2015-3.33%-1.48%-0.15%-3.66%-7.22%-10.36%-11.56%-32.62%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of ABVX.PA is 20, indicating that it is in the bottom 20% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of ABVX.PA is 2020
ABVX.PA (Abivax SA)
The Sharpe Ratio Rank of ABVX.PA is 1919Sharpe Ratio Rank
The Sortino Ratio Rank of ABVX.PA is 2020Sortino Ratio Rank
The Omega Ratio Rank of ABVX.PA is 2020Omega Ratio Rank
The Calmar Ratio Rank of ABVX.PA is 2525Calmar Ratio Rank
The Martin Ratio Rank of ABVX.PA is 1717Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Abivax SA (ABVX.PA) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


ABVX.PA
Sharpe ratio
The chart of Sharpe ratio for ABVX.PA, currently valued at -0.47, compared to the broader market-4.00-2.000.002.00-0.47
Sortino ratio
The chart of Sortino ratio for ABVX.PA, currently valued at -0.34, compared to the broader market-4.00-2.000.002.004.00-0.34
Omega ratio
The chart of Omega ratio for ABVX.PA, currently valued at 0.95, compared to the broader market0.501.001.500.95
Calmar ratio
The chart of Calmar ratio for ABVX.PA, currently valued at -0.30, compared to the broader market0.001.002.003.004.005.006.00-0.30
Martin ratio
The chart of Martin ratio for ABVX.PA, currently valued at -1.12, compared to the broader market-10.000.0010.0020.00-1.12
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.64, compared to the broader market-4.00-2.000.002.002.64
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.52, compared to the broader market-4.00-2.000.002.004.003.52
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.48, compared to the broader market0.501.001.501.48
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 2.34, compared to the broader market0.001.002.003.004.005.006.002.34
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 16.15, compared to the broader market-10.000.0010.0020.0016.15

Sharpe Ratio

The current Abivax SA Sharpe ratio is -0.47. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Abivax SA with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00MayJuneJulyAugustSeptemberOctober
-0.47
2.21
ABVX.PA (Abivax SA)
Benchmark (^GSPC)

Dividends

Dividend History


Abivax SA doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-80.00%-60.00%-40.00%-20.00%0.00%MayJuneJulyAugustSeptemberOctober
-72.31%
-0.86%
ABVX.PA (Abivax SA)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Abivax SA. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Abivax SA was 83.93%, occurring on Mar 16, 2023. The portfolio has not yet recovered.

The current Abivax SA drawdown is 72.31%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-83.93%Jan 5, 2021567Mar 16, 2023
-81.43%Jun 29, 2015300Aug 25, 2016852Dec 24, 20191152
-50.96%Dec 31, 201953Mar 13, 2020200Dec 23, 2020253
-1.21%Dec 24, 20201Dec 24, 20201Dec 28, 20202

Volatility

Volatility Chart

The current Abivax SA volatility is 9.85%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%MayJuneJulyAugustSeptemberOctober
9.85%
3.97%
ABVX.PA (Abivax SA)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Abivax SA over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Abivax SA.


Loading data...

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items